GOLD Program for Osteoarthritis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Osteoarthritis+4 MoreGOLD Program - Behavioral
Eligibility
8 - 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study a psychological intervention delivered online to parents of children with cancer. The intervention will be evaluated to see if it is effective.

Eligible Conditions
  • Leukemia
  • Osteoarthritis
  • Leukemia, Lymphocytic
  • Brain and Nervous System
  • Acute Myeloid Leukemia (AML)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 month

1 month
Acceptability of the GOLD Program for caregivers
Number of caregivers who enroll in the GOLD program

Trial Safety

Trial Design

2 Treatment Groups

Treatment-as-Usual (TAU)
1 of 2
GOLD Psychosocial Program
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: GOLD Program · No Placebo Group · N/A

GOLD Psychosocial Program
Behavioral
Experimental Group · 1 Intervention: GOLD Program · Intervention Types: Behavioral
Treatment-as-Usual (TAU)
Behavioral
ActiveComparator Group · 1 Intervention: Treatment as usual (TAU) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,170 Previous Clinical Trials
35,768,243 Total Patients Enrolled
16 Trials studying Osteoarthritis
5,028 Patients Enrolled for Osteoarthritis
Victoria E. Cosgrove, PhDPrincipal InvestigatorStanford University

Eligibility Criteria

Age 8 - 18 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: